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doi:10.1Objectives: Recently, concern has been expressed about the transfusion of older red blood cells after cardiac sur-
gery. We tested the hypothesis that longer storage of transfused red blood cells increases the risk of early and late
mortality in patients who undergo coronary artery bypass grafting.
Methods: We retrospectively analyzed data of patients who underwent isolated coronary artery bypass grafting
between January 1998 and December 2007 in Catharina Hospital, Eindhoven, The Netherlands, and received up
to 10 U of red blood cells intraoperatively or during the first 5 postoperative days. The patients were divided into 3
groups according to the storage time of the red blood cells, with a cutoff point of 14 days, as follows: ‘‘only youn-
ger blood’’ (n ¼ 1422), ‘‘only older blood’’ (n ¼ 1719), and at least 1 U of older RBCs (‘‘any older blood’’;
n ¼ 2175).
Results: The mean follow-up time was 1693 1058 days (range, 0–3708 days). The median follow-up time was
1629 days. Univariate and multivariate logistic regression analyses revealed that the number of transfused units
but not the storage time of blood entered either as a continuous variable or as a dichotomous variable with a cutoff
point of 14 days was a risk factor for early mortality. Neither the number of transfused units nor the storage time
was an independent risk factor for late mortality. Log-rank testing revealed no statistical difference in survival
among the groups.
Conclusions: The storage time of transfused red blood cells is not a risk factor for early or late mortality in
patients who undergo coronary artery bypass grafting. (J Thorac Cardiovasc Surg 2011;141:231-7)Critically ill patients, including those who undergo cardiac
surgery, experience more severe complications if they re-
ceive blood transfusions.1-3 The storage time of red blood
cells (RBCs) might affect the risk of experiencing those
complications4-12 because RBCs undergo structural and
functional changes that reduce function and viability after
transfusion.12-16 Recently, some,17,18 but not all,19-21
investigators have expressed their concern about using
older RBCs for transfusion during or after cardiac surgery.
In those reports several end points in heterogeneous
patient populations were mentioned. We therefore
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Mincreased the risk of early or late mortality in a large group
of patients who underwent coronary artery bypass grafting
(CABG) at a single medical center.
MATERIALS AND METHODS
Patients
This study included the data of all adult patients (age 18 years) who
underwent isolated CABG in a single medical center at Catharina Hospital,
Eindhoven, The Netherlands, between January 1998 and December 2007.
Clinical data (including demographic information, risk factors, and compli-
cations) from January 1998 through December 2007 were collected in
a database. All patients who received between 1 and 10 U of RBCs intrao-
peratively or during the first 5 postoperative days were included in this
study. Patients who received more than 10 U of RBCs during that period
were excluded.
Approval was obtained from the institution’s research review board
before the initiation of the study. Data concerning blood transfusions and
the storage time of RBCs were collected from the database of the hospital
transfusion service. For every patient, the maximum storage time of the
transfused RBCs was used for analysis. The patients were divided into 3
groups according to the storage time of the RBCs they received: the
‘‘only younger blood’’ group (n ¼ 1422), the ‘‘only older blood’’ group
(n ¼ 1719), and those who received at least 1 U of older RBCs (the ‘‘any
older blood’’ group, n ¼ 2175). The cutoff point for duration of storage
of RBCs was 14 days. In this study ‘‘younger blood’’ refers to RBCs youn-
ger than 14 days, and ‘‘older blood’’ refers to RBCs older than 14 days. Pa-
tients in the only older RBCs group were also included in the any older
RBCs group. Leucocyte reduction was performed for all RBC units before
storage and within 24 hours after donation. RBCs were reconstituted with
SAG-mannitol to a hematocrit value of 60%  5%, which enabled a max-
imum storage time of 35 days.rdiovascular Surgery c Volume 141, Number 1 231
Abbreviations and Acronyms
CABG ¼ coronary artery bypass grafting
COPD ¼ chronic obstructive pulmonary
disease
CrCl ¼ creatinine clearance
ECC ¼ extracorporeal circulation
EF ¼ ejection fraction
FFP ¼ fresh frozen plasma
PVD ¼ peripheral vascular disease
RBC ¼ red blood cell
2,3-DPG ¼ 2,3-Diphosphoglycerate
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MOperative Techniques
All patients received short-acting anesthetic drugs to facilitate early ex-
tubation. Normothermic extracorporeal circulation (ECC) was performed
with nonpulsatile flow. According to the surgeon’s preference, either cold
intermittent crystalloid cardioplegia (St Thomas’ solution) or intermittent
warm blood cardioplegia was used to induce and maintain cardioplegic ar-
rest. All patients who underwent CABG with the use of ECC received low-
dose aprotinin (2 million KIU) during ECC that was administered in the
prime solution of the ECC. (This was the regular practice in Catharina hos-
pital in which the procedure was performed.) Patients who underwent off-
pump surgery did not receive aprotinin.
During the study period, we have maintained the same policy regarding
preoperative antiplatelet drugs and oral anticoagulants. Patients continued
the use of aspirin until the day before the operation. Clopidogrel was discon-
tinued 5 days preoperatively, and warfarin was discontinued 3 days
preoperatively.
Follow-up Data
Follow-up data on the mortality of the patients studied were gathered
from the databases of Dutch health insurance companies. Initially, the
data of 9% of the total patient group could not be retrieved from those da-
tabases. To obtain mortality data for those patients, we contacted the appro-
priate general practitioners (or, if necessary, the authorities) of the cities in
which the patients lived at the time of their operation. Early mortality was
defined as death within 30 days postoperatively or death at any time if the
patient did not leave the hospital or a transfer tertiary hospital alive, whereas
late mortality was defined as any-cause mortality at later than 30 days post-
operatively.
Statistical Analyses
Discrete variables were compared with the c2 test and are presented as
numbers and percentages. Continuous variables were compared with the
t test and analysis of variance and are presented as the mean  standard
deviation. Univariate and multivariate logistic regression analyses were per-
formed to investigate the effect of biomedical variables on early mortality.
Multivariate analyses were used to test for the potentially confounding ef-
fects of biomedical and demographic factors on outcome. Cox proportional
hazard regression analyses were performed for the same analyses of late
mortality. If they were statistically significant at a P value of less than
.05, confounders were included in the multivariable logistic and Cox regres-
sion analyses. Factors that were statistically significant in the univariate
analyses were entered in a multivariate model together with items of interest
(the number of transfused blood components and the maximum storage time
per blood component as a continuous variable and as a dichotomous vari-
able). Long-term survival was described with the Kaplan–Meier method.
The comparison of long-term survival in the study groups was performed232 The Journal of Thoracic and Cardiovascular Surgwith log-rank statistics. The zero time point indicates the time of CABG.
Hazard ratios with 95% confidence intervals are reported. All statistical
analyses were performed with SPSS software (version 15.0; SSPS, Inc,
Chicago, Ill).RESULTS
During a 10-year period (January 1998 through December
2007), 10,626 adult patients underwent isolated CABG in
Catharina Hospital, Eindhoven, The Netherlands. A total
of 3597 patients received at least 1 U of RBCs periopera-
tively and were included in this study. After 122 patients
who were lost to follow-up were excluded, we found that
1422 of the remaining patients received younger RBCs
(the only younger blood group), 2175 patients received at
least 1 U of older RBCs (the any older blood group), and
1719 patients received older RBCs (the only older blood
group). The mean follow-up time was 1693  1058 days
(range, 0–3708 days), with 0 days for operative deaths.
The median follow-up time was 1629 days.
The baseline characteristics of the patients who received
only younger blood, any older blood, and only older blood
are shown in Table 1. Patients who received only younger
blood were relatively younger (66.7 vs 67.6 years), more of-
ten had chronic obstructive pulmonary disease (COPD;
14.7% vs 12%), and had a higher preoperative hemoglobin
level (13.2 vs 12.9 g. dL1) than did patients of the any older
blood or only older blood groups. In the only older blood
group of patients, the number of grafts was higher (3.4 vs
3.5), but the percentage of re-exploration was less (11.7%
vs 9.0%). The number of transfused RBC units was higher
in the any older blood group than in the only younger blood
group and lower in the only older blood group than in the
only younger blood group. The number of transfused units
of fresh frozen plasma (FFP) and platelets were highest in
the any older blood group. Late mortality occurred more of-
ten in patients who received younger blood, but no differ-
ence was found in the incidence of early mortality among
the 3 groups (Table 2).
Risk factors for early mortality identified by means of uni-
variate logistic regression analysis and for late mortality
identified by means of Cox regression analyses are shown
in Table 3. When the maximum storage time was used as
a continuous variable, having received at least 1 U of older
RBCs or only older blood was not identified as a risk for ei-
ther early or late mortality. However, the number of trans-
fused units of RBCs, FFP, and platelets were significant
for both early and late mortality.
Other risk factors for early mortality were age, female sex,
COPD, diabetes, low creatinine clearance (CrCl), a left ven-
tricular ejection fraction (EF) of less than 35%, a low preop-
erative hemoglobin level, previous cardiac surgery,
peripheral vascular disease (PVD), emergency operation,
perioperative myocardial infarction, or re-exploration
for any cause. For late mortality, the risk factors were age,ery c January 2011
TABLE 1. Baseline characteristics stratified by the duration of storage of RBCs
Only younger RBCs
(n ¼ 1422)
Any older RBCs
(n ¼ 2175) P value
Only older RBCs
(n ¼ 1719) P Value
Preoperative factors*
Age (y) 66.7  9.4 67.6  9.2 .06 67.6  9.2 .011
Male sex 847 (59.6) 1244 (57.2) .167 977 (56.8) .127
Diabetes 327 (23.0) 499 (22.9) .968 401 (23.3) .832
Hypertension 601 (42.3) 951 (43.7) .390 772 (44.9) .139
COPD 209 (14.7) 270 (12.4) .050 207 (12.0) .030
PVD 179 (12.6) 307 (14.1) .195 244 (14.2) .208
Left ventricular EF<35% 73 (5.3) 87 (4.2) .137 65 (4.0) .080
CrCl 64.0  21.1 63.1  21.6 .233 63.6  21.6 .669
Emergency operation 105 (7.4) 176 (8.1) .447 119 (6.9) .626
Hb (g.dL1) 13.2  1.3 12.9  1.4 <.0001 13.0  1.4 <.0001
Redo cardiac surgery 142 (10.0) 198 (9.1) .382 137 (8.0) .051
Perioperative factors
No. of grafts 3.4  1.1 3.4  1.1 .054 3.5  1.1 .019
Off-pump surgery 60 (4.2) 94 (4.3) .933 78 (4.5) .727
ECC time 64.2  33.5 64.0  32.1 .864 63.0  30.8 .314
Re-exploration 167 (11.7) 263 (12.1) .793 154 (9.0) .011
Perioperative MI 71 (5.0) 123 (5.7) .407 83 (4.8) .868
No. of RBC units 2.6  1.5 2.8  1.7 <.0001 2.4  1.4 .004
No. of FFP units 0.42  1.15 0.54  1.30 .005 0.40  1.08 .579
No. of platelet units 0.06  0.30 0.10  0.39 <.0001 0.08  0.35 .075
RBC, Red blood cell; COPD, chronic obstructive pulmonary disease; PVD, peripheral vascular disease; EF, ejection fraction; CrCl, creatinine clearance; Hb, hemoglobin level;
ECC time, duration of extracorporeal circulation; MI, myocardial infarction; FFP, fresh frozen plasma. *Results are expressed as the mean  standard deviation or as numbers
(percentages).
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Mfemale sex, COPD, diabetes, low CrCl, a left ventricular EF
of less than 35%, a lower preoperative hemoglobin level,
previous cardiac surgery, PVD, hypertension, the number
of grafts, perioperative myocardial infarction, re-
exploration, the use of ECC, and the year of operation.
All risk factors identified by means of univariate analyses
were entered into the multivariate logistic regression and the
multivariate Cox regression model. The results are shown in
Table 4. When the maximum storage time was used as a con-
tinuous variable, having received at least 1 U of older RBCs
or only older blood was not a risk factor for early or late mor-
tality. Predictors of early mortality were the number of RBC
units, advanced age, COPD, diabetes, a left ventricular EF of
less than 35%, and perioperative myocardial infarction. The
numbers of units of FFP and platelets were not significant
predictors of late mortality. Predictors of late mortality
were advanced age, male sex, COPD, diabetes, low CrCl
clearance, a left ventricular EF of less than 35%, a lower pre-
operative hemoglobin level, PVD, hypertension, and perio-
perative myocardial infarction. The survival curves ofTABLE 2. Early and late mortality stratified by the duration of storage of
End point
Younger RBCs group
(n ¼ 1422)
Any older RBCs g
(n ¼ 2175)
Early mortality 52 (3.7%) 16 (4.9%)
Late mortality 258 (18.1%) 327 (15.0%)
RBC, Red blood cell. *Compared with the younger RBCs group.
The Journal of Thoracic and Capatients who received a transfusion of younger blood or at
least 1 U of older RBCs (Figure 1) and those who received
younger blood or only older blood (Figure 2) were similar,
with P values of .269 and .806, respectively.
DISCUSSION
In this retrospective analysis of 3597 patients who re-
ceived a transfusion of RBCs during or after CABG, the
storage time of the transfused RBCs was not a significant
predictor of early or late mortality. The effect of the transfu-
sion of stored blood on the outcomes of patients who
undergo cardiac surgery remains controversial.17-21 That
controversy might be due to the various patient
populations studied, differences in study design or
analysis, or different methods of blood storage. Vamvakas
and Carven19 studied the effect of the length of blood storage
on postoperative morbidity in 268 consecutive patients who
received a blood transfusion after CABG. Those authors
found no association between the age of the transfused blood
and the incidence of postoperative morbidity according toRBCs
roup*
P value
Only older RBCs group*
(n ¼ 1719) P value
.096 67 (3.9%) .778
.014 235 (13.7%) .001
rdiovascular Surgery c Volume 141, Number 1 233
TABLE 3. Univariate logistic regression analyses of risk factors for early mortality and Cox regression analyses for late mortality
Early mortality Late mortality
Risk factors Odds ratio (95% CI) P value Hazard ratio (95% CI) P value
Preoperative factors
Age (y)* 1.086 (1.067–1.105) <.0001 1.091 (1.083–1.099) <.0001
Male sex 0.70 (0.52–0.94) .019 0.85 (0.75–0.97) .021
COPD 2.05 (1.49–2.82) <.0001 1.94 (1.68–2.23) <.0001
Diabetes 1.42 (1.05–1.91) .023 1.73 (1.52–1.96) <.0001
Preoperative CrCl* 0.965 (0.959–0.972) <.0001 0.967 (0.964–0.970) <.0001
Left ventricular EF<35% 5.90 (4.00–8.71) <.0001 2.64 (2.10–3.31) <.0001
Preoperative Hb* 0.725 (0.662–0.795) <.0001 0.731 (0.702–0.761) <.0001
Redo cardiac surgery 3.40 (2.37–4.87) <.0001 1.60 (1.32–1.94) <.0001
PVD 1.58 (1.11–2.25) .012 2.29 (1.98–2.64) <.0001
Emergency operation 5.69 (3.98–8.14) <.0001 1.27 (0.98–1.66) .071
Hypertension 0.97 (0.70–1.21) .630 1.22 (1.08–1.37) .001
Perioperative and postoperative factors
No. of grafts* 0.956 (0.850–1.076) .457 1.084 (1.031–1.140) .002
Perioperative MI 6.00 (4.03–8.94) <.0001 1.82 (1.37–2.42) <.0001
Re-exploration 4.50 (3.17–6.39) <.0001 1.39 (1.11–1.75) .004
Off-pump surgery 0.73 (0.43–1.24) .251 0.68 (0.52–0.89) .005
Year of operation* 0.959 (0.915–1.005) .077 0.961 (0.934–0.989 .006
Maximum storage of RBCs
per patient*
1.017 (0.991–1.045) .206 1.013 (0.999–1.027) .071
Any older RBCs 1.35 (0.96–1.89) .083 1.03 (0.87–1.21) .714
Only older RBCs 1.06 (0.73–1.54) .725 0.96 (0.80–1.14) .665
No. of FFP units* 1.378 (1.262–1.505 <.0001 1.143 (1.075–1.215) <.0001
No. of platelet units* 2.360 (1.812–3.075) <.0001 1.295 (1.005–1.668) .046
No. of RBC units* 1.441 (1.374–1.511) <.0001 1.162 (1.131–1.193) <.0001
CI, Confidence interval; COPD, chronic obstructive pulmonary disease; CrCl, creatinine clearance; EF, left ventricular ejection fraction; Hb, hemoglobin level; PVD, peripheral
vascular disease, MI, myocardial infarction; RBCs, red blood cells; FFP, fresh frozen plasma. *Entered as a continuous variable.
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Similar results were demonstrated by van de Watering and
colleagues,20 who could not show an effect of RBC storage
time on mortality and morbidity in their analysis of 2732 pa-
tients who had undergone CABG. However, those authors
did not exclude the negative effect of older blood on postop-
erative infection.20 Koch and associates17 and Basran and
coworkers18 found that the transfusion of older RBCs was
a risk factor for various complications and increased early
mortality after cardiac surgery. In the study by Koch and as-
sociates,17 more patients who received older blood exhibited
preoperative mitral regurgitation, left ventricular dysfunc-
tion, and PVD. In our study the baseline characteristics of
the groups studied were similar; this rendered confounding
effects unlikely. By using multivariate analysis, we excluded
the possible negative effects of those risk factors.
Our retrospective analysis was designed to minimize the ef-
fects of other confounding variables on early and late out-
come. First, we only studied patients who underwent
CABG because the complexity of the surgical procedure
can affect both early and late outcomes. Other studies
included patients who underwent valve surgery17 or redo
surgery.18
Second, we excluded patients who received more than 10
U of RBCs (0.5% of the total CABG population). The need234 The Journal of Thoracic and Cardiovascular Surgfor such a large number of transfused blood units reflects
a major complication or a possible surgical catastrophic
event. Those patients usually have a higher incidence of
morbidity, mortality, or both. The poor outcomes in such
cases cannot be attributed only to the storage time of trans-
fused RBCs. Furthermore, in addition to the 2 groups who
received only younger blood or only older blood, we also ex-
amined a third group of patients: those who received at least
1 U of old RBCs (the any older blood group). In that way we
tested the hypothesis that having received any number of
units of older RBCs can affect outcome. The absence of a sig-
nificant difference in early and late mortality disproves that
hypothesis. We arbitrarily dichotomized our study popula-
tion into groups with a cutoff point of 14 days. Koch and
associates17 used the same storage time (14 days) to define
their ‘‘newer blood’’ and ‘‘older blood’’ groups. van de
Watering and colleagues20 used a storage time of 18 days.
Other authors have used storage time as a continuous vari-
able in their study analyses.18,21 These factors can also
explain the controversy that exists concerning the effect of
storage time on prognosis.
It has been assumed that preserved RBCs undergo func-
tional and structural changes that begin after 2 weeks of stor-
age.13-16 The deformability of RBCs reduces with longer
storage time; this leads to reduced microvascular flow.13,14ery c January 2011
TABLE 4. Results of multivariate logistic regression analyses for early mortality and Cox regression analyses for late mortality
Risk factors
Early mortality Late mortality
OR (95% CI) P value HR (95% CI) P value
Max ST RBCs* 1.000 (0.969–1.032) .994 1.007 (0.993–1.023) .330
Any older RBCs 1.13 (0.76–1.66) .529 1.02 (0.85–1.22) .763
Only older RBCs 1.02 (0.67–1.56) .894 1.01 (0.83–1.23) .872
No. of RBC units* 1.262 (1.125–1.416) <.0001 1.010 (0.947–1.077) .764
No. of FFP units* 0.863 (0.721–1.033) .109 1.056 (0.956–1.165) .282
No. of platelet units* 1.321 (0.832–2.097) .238 1.027 (0.725–1.454) .882
Age (y)* 1.065 (1.035–1.097) <.0001 1.051 (1.036–1.066) <.0001
Male sex 1.40 (0.93–2.12) .102 1.68 (1.28–2.03) <.0001
COPD 2.20 (1.43–3.37) <.0001 1.91 (1.55–2.37) <.0001
Diabetes 1.60 (1.06–2.41) .023 1.39 (1.14–1.69) .001
CrCl* 0.991 (0.979–1.003) .124 0.980 (0.974–0.986) <.0001
Left ventricular EF<35% 4.74 (2.71–8.27) <.0001 1.95 (1.37–2.77) <.0001
Preoperative Hb* 1.024 (0.896–1.171) .726 0.813 (0.759–0.870) <.0001
Redo cardiac surgery 1.11 (0.61–2.00) .726 1.17 (0.87–1.56) .290
PVD 1.22 (0.76–1.98) .400 1.54 (1.24–1.92) <.0001
Emergency surgery 1.86 (0.85–4.03) .116
Hypertension 1.20 (1.00–1.43) .044
No. of grafts 0.974 (0.894–1.062) .553
Perioperative MI 4.33 (2.56–7.35) <.0001 1.90 (1.31–2.75) .001
Re-exploration 1.62 (0.90–2.89) .101 1.29 (0.91–1.81) .141
Off-pump surgery 0.78 (0.43–1.41) .418
Year of operation 0.934 (0.892–0.978) .004
OR, Odds ratio; CI, confidence interval; HR, hazard ratio; Max ST RBCs, maximum storage time of red blood cells per patient; RBCs, red blood cells; FFP, fresh frozen plasma;
COPD, chronic obstructive pulmonary disease; CrCl, creatinine clearance; EF, ejection fraction; Hb, hemoglobin level; PVD, peripheral vascular disease; MI, myocardial infarc-
tion. *Entered as a continuous variable.
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because of the depletion of 2,3-diphosphoglycerate
(2,3-DPG).22 The transfusion of stored rigid RBCs with
low oxygen transport capacity could thus impede blood
flow and predispose the patient to ischemia. Our study does
not support that hypothesis because we found that the effect
of a transfusion of older blood on mortality was not signifi-
cant. It is possible that the effect of storage of RBCs on oxy-
gen delivery is only physiologically significant, reversible, or
insufficient to affect mortality. After transfusion, 2,3-DPG
levels usually normalize within a few days.23 Tinmouth
and Chin-Yee24 indicated that the transfusion of 2,3-DPG–
depleted blood in human subjects and animals produced no
impairment in work performance, mortality, or tolerance of
hypoxemic conditions. In addition, various storage condi-
tions can retard the deterioration of RBCs. Van de Watering
and colleagues20 did not find an association between the stor-
age time of RBCs and adverse outcome after CABG, and
their results confirm those of our study. Differences in
blood-withdrawal techniques, processing, and storage proto-
cols for blood components among countries might explain
the varying results. The protocol for the preservation of
RBCs in The Netherlands seems to be safe for patients who
need a transfusion of RBCs after CABG.
We suggest that the possible harm caused by the transfu-
sion of stored RBCs must be weighed against the clinicalThe Journal of Thoracic and Cabenefits of transfusion. Prospective randomized studies are
needed to determine the significance of storage effects of
transfused RBCs after CABG. However, this is unlikely to
occur because of the general shortage of blood for transfu-
sion, logistical difficulties, and ethical issues worldwide.
Study Limitations
In this retrospective study other factors that are unac-
counted for in the described demographic characteristics
might have caused the differences cited. A prospective
randomized trial could eliminate that shortcoming. Unfortu-
nately, we were not able to report the causes of death in the
study subjects. The study end point was all-cause mortality.
No data were addressed about postoperative complications,
such as pulmonary or renal complications, prolonged
hospital stay, or postoperative infections. Except for patients
undergoing off-pump coronary artery bypass, other patients
received aprotinin, which might reduce the need for transfu-
sion and hence early outcome.25 Our study is, to our
knowledge, the second single-center study on the effect of
storage time of RBCs after CABG that has been performed
in The Netherlands. Whether the results of Dutch studies ap-
ply to patients undergoing CABG in countries in which
other types of blood-withdrawal, processing, and storage
protocols of RBCs are implemented remains to be investi-
gated.rdiovascular Surgery c Volume 141, Number 1 235
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FIGURE 1. Kaplan–Meier curves and storage times of red blood cells
(RBC) in patients who received only younger RBCs and those who received
at least 1 U of older RBCs.
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FIGURE 2. Kaplan–Meier curves and storage times of red blood cells
(RBC) in patients who received only younger RBCs and those who received
only older RBCs.
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MCONCLUSIONS
In a group of 3597 (of a total of 10,626) patients who re-
ceived between 1 and 10 U of RBCs within the first 5 post-
operative days after CABG, we found a clear correlation
between the number of transfused RBCs and early mortality.
The storage time of RBCs was not a predictor of early or late
mortality.
We thank the Sanquin Blood Supply Foundation in The Nether-
lands for its help in collecting the data for this study. We also thank
Professor A. Brand and Dr L. van de Watering for their support and
advice in preparing the manuscript.
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